Filing Details
- Accession Number:
- 0001424422-18-000007
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-22 18:39:15
- Reporting Period:
- 2018-10-18
- Accepted Time:
- 2018-10-22 18:39:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1504167 | Biopharmx Corp | BPMX | Pharmaceutical Preparations (2834) | 593843182 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1637670 | Stephen Morlock | 1505 Adams Drive Menlo Park CA 94025 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-10-18 | 439,099 | $0.19 | 434,857 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-10-19 | 214,091 | $0.18 | 220,766 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-10-22 | 220,766 | $0.18 | 0 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-10-22 | 251,071 | $0.18 | 0 | No | 4 | S | Indirect | By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03 |
Billionaire Hedge Funds
